Small Lymphocytic Lymphoma (SLL)

>

CURE’s small lymphocytic lymphoma (SLL) page is a go-to resource for oncology news and updates in the world of SLL. Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in small lymphocytic lymphoma (SLL).

Latest News

Illustration of woman with light brown hair.
You Need Tough Skin With Cancer

February 5th 2025

Living with lymphoma for 15 years, I developed a concerning rash post-vacation, which led to a leukocytoclastic vasculitis diagnosis.

Illustration of blood cells.
Brukinsa May Improve Efficacy Versus Imbruvica in R/R CLL and SLL

January 28th 2025

Illustration of woman with red hair.
Always Bring a Second Set of Ears to Your Oncology Checkup!

January 13th 2025

Illustration of a woman with long curly red hair.
Keeping Cancer Out of the Closet

December 17th 2024

Illustration of CLL cells.
Brukinsa Supported as First-Line Treatment for Patients With CLL/SLL

December 9th 2024

More News

Imbruvica Yields Favorable Safety Outcomes in Two Types of Lymphomas

Imbruvica Yields Favorable Safety Outcomes in Two Types of Lymphomas

Katie Kosko
November 12th 2018

Imbruvica (ibrutinib) is a safe treatment for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma (MCL), according to a pooled analysis of four clinical trials.

FDA Approves Copiktra for Two Types of Blood Cancer

FDA Approves Copiktra for Two Types of Blood Cancer

Brielle Benyon
September 25th 2018

The drug was approved for adults with chronic lymphocytic leukemia and small lymphocytic lymphoma. And was granted an accelerated approval for follicular lymphoma.

<12